These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17382591)

  • 41. Ex vivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis.
    Morosini M; Meloni F; Uccelli M; Marone Bianco A; Solari N; Fietta AM
    Int J Tuberc Lung Dis; 2005 Jul; 9(7):753-9. PubMed ID: 16013770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
    Dubey S; Shukla P; Nityanand S
    Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of serum IL-1, IL-2 and IFN-γ levels in untreated pulmonary tuberculosis patients: role in pathogenesis.
    Katti MK
    Arch Med Res; 2011 Apr; 42(3):199-201. PubMed ID: 21722815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cytokine producing ability of peripheral blood mononuclear cells in the clinical course of pulmonary tuberculosis].
    Nakaya M; Yoneda T; Kobayashi A; Onohara Y; Ikoma Y; Fukuoka A; Tomoda K; Takenaka H; Okamura H; Yamamoto C; Fukuoka K; Tokuyama T; Okamoto Y; Yoshikawa M; Tsukaguchi K; Narita N
    Kekkaku; 1997 Jun; 72(6):403-10. PubMed ID: 9248274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes and significance of peripheral blood T cell subsets, soluble interleukin-2 receptor and interferon-gamma in patients with retreatment pulmonary tuberculosis and initial treatment tuberculosis].
    Zhang SJ; Xiao HP
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):884-7. PubMed ID: 22333498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IFNG +874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis.
    Vallinoto AC; Graça ES; Araújo MS; Azevedo VN; Cayres-Vallinoto I; Machado LF; Ishak MO; Ishak R
    Hum Immunol; 2010 Jul; 71(7):692-6. PubMed ID: 20353805
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reaction.
    Nagasawa M; Isoda T; Itoh S; Kajiwara M; Morio T; Shimizu N; Ogawa K; Nagata K; Nakamura M; Mizutani S
    Am J Hematol; 2006 May; 81(5):340-8. PubMed ID: 16628730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls.
    Faurholt-Jepsen D; Aabye MG; Jensen AV; Range N; Praygod G; Jeremiah K; Changalucha J; Faurholt-Jepsen M; Jensen L; Jensen SM; Krarup H; Ravn P; Friis H; Andersen AB
    Scand J Infect Dis; 2014 May; 46(5):384-91. PubMed ID: 24621055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tuberculous lymphadenitis: skin delayed-type hypersensitivity reaction and cellular immune responses.
    Khalil EA; Elnour AA; Musa AM; Elagib AA; Hassab Elgawi SH; Ismail WM; Elzaki KE
    West Afr J Med; 2011; 30(3):193-6. PubMed ID: 22120485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum granulysin level as a novel prognostic marker in patients with gastric carcinoma.
    Saigusa S; Ichikura T; Tsujimoto H; Sugasawa H; Majima T; Kawarabayashi N; Chochi K; Ono S; Kinoshita M; Seki S; Ogawa K; Mochizuki H
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1322-7. PubMed ID: 17688669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential function of granulysin, other related effector molecules and lymphocyte subsets in patients with TB and HIV/TB coinfection.
    Pitabut N; Sakurada S; Tanaka T; Ridruechai C; Tanuma J; Aoki T; Kantipong P; Piyaworawong S; Kobayashi N; Dhepakson P; Yanai H; Yamada N; Oka S; Okada M; Khusmith S; Keicho N
    Int J Med Sci; 2013; 10(8):1003-14. PubMed ID: 23801887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Granulysin-producing cytotoxic T cells in the mucocutaneous lesions of Behçet disease: a distinct inflammatory response from erythema nodosum.
    Yamasaki O; Morizane S; Aochi S; Ogawa K; Oono T; Iwatsuki K
    Clin Exp Dermatol; 2011 Dec; 36(8):903-7. PubMed ID: 21883401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased prevalence of peripheral blood granulysin-producing cytotoxic T lymphocytes in preeclampsia.
    Molvarec A; Shiozaki A; Ito M; Toldi G; Stenczer B; Szarka A; Nakashima A; Vásárhelyi B; Rigó J; Saito S
    J Reprod Immunol; 2011 Sep; 91(1-2):56-63. PubMed ID: 21763002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating granulysin levels in healthcare workers and latent tuberculosis infection estimated using interferon-gamma release assays.
    Thuong PH; Tam DB; Sakurada S; Hang NT; Hijikata M; Hong LT; Ngoc PT; Anh PT; Cuong VC; Matsushita I; Lien LT; Keicho N
    BMC Infect Dis; 2016 Oct; 16(1):580. PubMed ID: 27756230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapeutic effects of granulysin/interleukin-12 recombinant M. smegmatis in a murine model of M. tuberculosis infection].
    Yang C; Wang YW; Yi ZJ; He YL; Li N; Xu L; Zhang L; Zhu DY
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):133-7. PubMed ID: 17445478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Granulysin: antimicrobial molecule of innate and acquired immunity in human tuberculosis].
    Wargnier A; Sasportes M; Lagrange PH
    Pathol Biol (Paris); 2005; 53(8-9):516-21. PubMed ID: 16081226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment.
    Pai M; Joshi R; Bandyopadhyay M; Narang P; Dogra S; Taksande B; Kalantri S
    Infection; 2007 Apr; 35(2):98-103. PubMed ID: 17401714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction in resting plasma granulysin as a marker of increased training load.
    Shing CM; Ogawa K; Zhang X; Nagatomi R; Peake JM; Suzuki K; Jenkins DG; Coombes JS
    Exerc Immunol Rev; 2007; 13():89-99. PubMed ID: 18198663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymphocyte subpopulations in active tuberculosis: association with disease severity and the QFT-GIT assay.
    Guglielmetti L; Cazzadori A; Conti M; Boccafoglio F; Vella A; Ortolani R; Concia E
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):825-8. PubMed ID: 23676170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis.
    Koguchi Y; Kawakami K; Uezu K; Fukushima K; Kon S; Maeda M; Nakamoto A; Owan I; Kuba M; Kudeken N; Azuma M; Yara S; Shinzato T; Higa F; Tateyama M; Kadota J; Mukae H; Kohno S; Uede T; Saito A
    Am J Respir Crit Care Med; 2003 May; 167(10):1355-9. PubMed ID: 12574077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.